Sfoglia per RIVISTA
EUROPEAN UROLOGY ONCOLOGY
Collezione AOU Novara

  

Items : 10

Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time? in European urology oncology / Eur Urol Oncol. 2025 Jun;8(3):597-600. doi: 10.1016/j.euo.2025.02.014. Epub 2025 Mar 14.

2025
AOU Novara

Hannan R; Mollica V; Palumbo C; Erdem S;

Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel. in European urology oncology / Eur Urol Oncol. 2025 Jun;8(3):616-622. doi: 10.1016/j.euo.2025.01.013. Epub 2025 Apr 10.

2025
AOU Novara

Marconi L; Kuusk T; Hora M; Klatte T; Dabestani S; Capitanio U; Abu-Ghanem Y; Campi R; Fernández-Pello S; Albiges L; Bedke J; Powles T; Volpe A; Ljungberg B; Bex A;

2024
AOU San Luigi di Orbassano
AOU Novara

Wang L; Qu L; Chen C; Li M; Feng X; Ge J; Zheng J; Wang S; Zhou X; Shi B; Xue W; Wang Z; Qin W; Chen M; Guo H; Zu X; Jiang J; Xia D; Liu Z; Wang G; Liang C; Xu N; Wang J; Rao Q; Miao H; Cheng J; Wang F; Gao J; Wang H; et alii...

2024
AOU Novara

Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; et alii...

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis. in European urology oncology / Eur Urol Oncol. 2024 Apr;7(2):179-188. doi: 10.1016/j.euo.2023.07.013. Epub 2023 Aug 12.

2024
AOU Novara

Messina C; Giunta EF; Signori A; Rebuzzi SE; Banna GL; Maniam A; Buti S; Cattrini C; Fornarini G; Bauckneht M; Greystoke A; Plummer R; Oing C; Rescigno P;

Management of Metastatic Nonclear Renal Cell Carcinoma: What Are the Options and Challenges? in European urology oncology / Eur Urol Oncol. 2021 Oct;4(5):843-850. doi: 10.1016/j.euo.2020.05.010. Epub 2020 Jun 15.

2021
AOU Novara

Volpe A; Hora M; Giannarini G; Bex A; Albiges L; Mir MC; Rouprêt M;

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. in European urology oncology / Eur Urol Oncol. 2021 Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24.

2021
AOU Novara

Klatte T; Ljungberg B; Meijer RP; Volpe A; Nisen H; Fernandéz-Pello S; Marconi L; Lam TB; Gudmundsson EO; Stewart GD; Järvinen P; Capitanio U; Beisland C; Powles T; Abu-Ghanem Y; Dabestani S; Bex A;

2020
AOU Novara

Fernández-Pello S; Hora M; Kuusk T; Tahbaz R; Dabestani S; Abu-Ghanem Y; Albiges L; Giles RH; Hofmann F; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A; Bensalah K;

2020
AOU Novara

Kuusk T; Marconi L; Kuczyk MA; Hora M; Hofmann F; Dabestani S; Giles RH; Albiges L; Ljungberg B; Bex A; Fernández-Pello S; Abu-Ghanem Y; Merseburger AS; Tahbaz R; Staehler M; Volpe A; Powles T; Lam TB; Bensalah K;

Role of Active Surveillance for Localized Small Renal Masses. in European urology oncology / Eur Urol Oncol. 2018 Aug;1(3):177-187. doi: 10.1016/j.euo.2018.05.001. Epub 2018 May 26.

2018
AOU Novara

Mir MC; Capitanio U; Bertolo R; Ouzaid I; Salagierski M; Kriegmair M; Volpe A; Jewett MAS; Kutikov A; Pierorazio PM;